| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.082 | 0.009 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.009 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.009 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.009 |